Cryptococcosis

On this page

Organism & Virulence - Crypto's ID & Arsenal

  • Organism: Cryptococcus neoformans (common, esp. AIDS) & C. gattii (tropics, immunocompetent/compromised).
    • Encapsulated yeast, 5-10 µm diameter.
    • Round to oval, reproduces by narrow-based budding.
    • Not dimorphic (yeast form only).
    • Cryptococcus neoformans with India ink stain
  • Virulence Factors (Crypto's Arsenal):
    • Polysaccharide Capsule: Major! Mainly GXM (glucuronoxylomannan).
      • Antiphagocytic, inhibits leukocyte migration, immunosuppressive.

      ⭐ The capsule is its primary virulence factor; visualized by India Ink (negative stain) as a clear halo.

    • Melanin Production: Via laccase.
      • Protects from oxidative stress & host enzymes; neurotropic. (📌 "MELANIN: Mighty & Mind-loving")
    • Phospholipase B: Host membrane damage, tissue invasion.
    • Urease: Produces $NH_3$, ↑pH, aids CNS invasion (BBB).
    • Thermotolerance: Grows at 37°C.

Epidemiology & Risk Factors - Who Gets Hit & How

  • Distribution & Species:
    • C. neoformans: Ubiquitous worldwide.
    • C. gattii: Predominantly tropical/subtropical; emerging temperate (Pacific NW).
  • Reservoirs:
    • C. neoformans: Soil enriched with pigeon guano.
    • C. gattii: Eucalyptus trees, decaying wood.
  • Transmission: Inhalation of airborne yeast/basidiospores. No human-to-human spread.
  • Risk Factors (C. neoformans):
    • Cellular Immunodeficiency (Major):
      • HIV/AIDS: CD4+ T-cell count < 100 cells/µL (most critical). 📌 AIDS-defining illness.
      • Solid organ transplant recipients (on immunosuppressive therapy).
      • Prolonged high-dose corticosteroid therapy.
      • Hematologic malignancies (e.g., lymphoma, CLL).
      • Sarcoidosis.
      • Biologic agents (e.g., TNF-α inhibitors).
    • C. gattii: Notably can infect immunocompetent individuals, unlike typical C. neoformans.

⭐ Globally, cryptococcal meningitis is a leading opportunistic infection and a major cause of mortality in patients with advanced HIV/AIDS.

Clinical Manifestations - Brain & Lung Invasion

  • Pulmonary Cryptococcosis:

    • Often asymptomatic in immunocompetent individuals.
    • Symptoms: Cough (productive or non-productive), low-grade fever, pleuritic chest pain, dyspnea, weight loss.
    • Radiology: Nodules (cryptococcomas), infiltrates (diffuse or lobar), pleural effusions, hilar lymphadenopathy.
    • Can disseminate, especially in immunocompromised.
  • Cryptococcal Meningoencephalitis (CM): Most common CNS manifestation.

    • Predominantly in immunocompromised (HIV/AIDS, CD4 < 100 cells/µL).
    • Symptoms: Headache (often severe, persistent), fever, altered mental status, lethargy, nausea, vomiting, neck stiffness, photophobia, seizures.
    • Cranial nerve palsies (esp. VI, VII, VIII) common.
    • ↑ Intracranial pressure (ICP) is a major cause of morbidity/mortality.

      ⭐ Raised ICP is a hallmark of cryptococcal meningitis and a poor prognostic indicator. Management often requires therapeutic lumbar punctures or shunting.

image

  • Other sites of dissemination (less common): Skin (papules, pustules, ulcers resembling molluscum contagiosum), bone, prostate, eyes (choroidoretinitis).

Diagnosis & Management - Unmasking & Eradicating

  • Diagnosis:
    • CSF analysis: ↑Protein, ↓Glucose, Lymphocytic pleocytosis.
    • India Ink: Encapsulated budding yeast (halos). Sensitivity ~50-80% in AIDS.
      • India ink stain of Cryptococcus neoformans in CSF
    • Cryptococcal Antigen (CrAg): Serum/CSF. Rapid, high Sensitivity & Specificity.

      ⭐ CrAg titers often correlate with fungal burden and can monitor therapeutic response.

    • Culture (SDA): Gold standard.
  • Management:
    • Manage ↑Intracranial Pressure (ICP): Aggressive! Therapeutic Lumbar Punctures (if Opening Pressure >25 $cm H_2O$); shunts if refractory.
    • Antifungal Therapy (Phased for CNS disease):
-   Induction (HIV+ or severe CNS): Liposomal Ampho B (LAmB) **3-4** mg/kg/d IV + Flucytosine (5-FC) **100** mg/kg/d PO (div. doses) x ≥**2** wks.
-   Consolidation: Fluconazole **400-800** mg/d PO x **8** wks.
-   Maintenance: Fluconazole **200** mg/d PO x ≥**1** yr.
-   Immune Reconstitution Inflammatory Syndrome (IRIS): Paradoxical worsening on ART; manage with NSAIDs/steroids if severe.

High‑Yield Points - ⚡ Biggest Takeaways

  • Cryptococcus neoformans: Encapsulated yeast from pigeon droppings; acquired by inhalation.
  • Key virulence: Large polysaccharide capsule (visualized by India Ink, resists phagocytosis).
  • High risk: HIV/AIDS patients (CD4 < 100 cells/µL), other immunocompromised states.
  • Predominant disease: Meningoencephalitis; also causes pulmonary and cutaneous infections.
  • Diagnosis: Cryptococcal antigen (CrAg) test (CSF/serum) is crucial; CSF India Ink for direct visualization.
  • Treatment: Amphotericin B + Flucytosine for induction, followed by Fluconazole maintenance.

Practice Questions: Cryptococcosis

Test your understanding with these related questions

A patient with AIDS presents with meningitis. India ink staining shows encapsulated yeasts. Which organism is most likely?

1 of 5

Flashcards: Cryptococcosis

1/10

_____ agar is used to demonstrate melanin production by Cryptococcus neoformans

TAP TO REVEAL ANSWER

_____ agar is used to demonstrate melanin production by Cryptococcus neoformans

Niger seed

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial